Research
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c693 (Published 09 February 2010) Cite this as: BMJ 2010;340:c693Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Appendix 1: Cohort assembly
- Data Supplement - Appendix 2: Characteristics of tamoxifen and antidepressant use
- Data Supplement - Appendix 3: Other antidepressant use among women receiving SSRIs during tamoxifen treatment
Related articles
- Editorial Published: 09 February 2010; BMJ 340 doi:10.1136/bmj.c783
- Paper Published: 24 March 2005; BMJ 330 doi:10.1136/bmj.38343.670868.D3
- PAPERS Published: 09 February 2005; BMJ doi:10.1136/bmj.38343.670868.D3
- PAPERSDepression, anxiety, or both in women with early breast cancer: five year observational cohort studyPublished: 04 February 2005; BMJ doi:10.1136/bmj.38343.670868.D3
- Research Published: 30 September 2016; BMJ 354 doi:10.1136/bmj.i5014
- Editorial Published: 30 September 2016; BMJ 354 doi:10.1136/bmj.i5309
- Clinical Review Published: 18 September 2023; BMJ 382 doi:10.1136/bmj-2022-071565
See more
- Breast cancer: Inaction on inequalities has led to unequal progress, say expertsBMJ April 16, 2024, 385 q854; DOI: https://doi.org/10.1136/bmj.q854
- Cancer: Fast tracked drugs often do not improve clinical outcomes, say researchersBMJ April 08, 2024, 385 q818; DOI: https://doi.org/10.1136/bmj.q818
- NHS rolls out fast tracked immunotherapy for advanced endometrial cancerBMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557
- Teledentistry may help in detecting oral cancers in current GP and dentist shortagesBMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512
- UK’s progress on cancer survival has slowed in past decade, figures showBMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290
Cited by...
- Advances in the care of breast cancer survivors
- Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with Antidepressants
- Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study
- Revisiting the drug interaction between tamoxifen and SSRI antidepressants
- Antidepressants and Platinum Drugs
- Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
- Tamoxifen and CYP2D6: A Contradiction of Data
- Acupuncture for Hot Flashes: Decision Making by Breast Cancer Survivors
- Hormone replacement therapy
- The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial
- Exercise Effects on Depressive Symptoms in Cancer Survivors: A Systematic Review and Meta-analysis
- Healthcare Professional Students Knowledge of Drug-Drug Interactions
- Hot Flashes: A Review of Pathophysiology and Treatment Modalities
- Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials
- Symptom Management in Metastatic Breast Cancer
- Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment
- Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
- Pharmacy Students Retention of Knowledge of Drug-Drug Interactions
- Critical issues associated with drug-drug interactions: Highlights of a multistakeholder conference
- Aromatase Inhibitors as Adjuvant Therapy for Breast Cancer
- Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
- Reply to R. Ferraldeschi et al
- Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen
- Authors' reply
- Why condemn fluoxetine?
- Do Selective Serotonin Reuptake Inhibitors Attenuate Tamoxifen's Benefits in Breast Cancer Survivors?
- Paroxetine Use Negates Benefits of Tamoxifen in Women with Breast Cancer
- Interaction of serotonin reuptake inhibitors with tamoxifen